↓ Skip to main content
What is this page? Embed badge

Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab

Overview of attention for article published in Oncologist, July 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 X users
facebook
1 Facebook page

Readers on

mendeley
11 Mendeley